ITMI20021725A1 - Composizioni farmaceutiche ad attivita' antibiotica. - Google Patents

Composizioni farmaceutiche ad attivita' antibiotica.

Info

Publication number
ITMI20021725A1
ITMI20021725A1 IT001725A ITMI20021725A ITMI20021725A1 IT MI20021725 A1 ITMI20021725 A1 IT MI20021725A1 IT 001725 A IT001725 A IT 001725A IT MI20021725 A ITMI20021725 A IT MI20021725A IT MI20021725 A1 ITMI20021725 A1 IT MI20021725A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
antibiotic activity
antibiotic
activity
pharmaceutical
Prior art date
Application number
IT001725A
Other languages
English (en)
Inventor
Sarah Faccin
Giovanni Gurrieri
Luca Pirrone
Luca Rampoldi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27638551&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20021725(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT001725A priority Critical patent/ITMI20021725A1/it
Publication of ITMI20021725A1 publication Critical patent/ITMI20021725A1/it
Priority to IL156615A priority patent/IL156615A/en
Priority to ZA200305040A priority patent/ZA200305040B/xx
Priority to NL1023790A priority patent/NL1023790C2/nl
Priority to PT102995A priority patent/PT102995B/pt
Priority to CA2434927A priority patent/CA2434927C/en
Priority to US10/615,781 priority patent/US7303755B2/en
Priority to CO03058787A priority patent/CO5480297A1/es
Priority to GR20030100300A priority patent/GR20030100300A/el
Priority to CH01238/03A priority patent/CH696718A5/it
Priority to FI20031078A priority patent/FI120080B/fi
Priority to DK200301097A priority patent/DK178348B1/da
Priority to JP2003200437A priority patent/JP4395338B2/ja
Priority to SI200300194A priority patent/SI21259B/sl
Priority to SE0302129A priority patent/SE527466C2/sv
Priority to BE2003/0427A priority patent/BE1017903A3/fr
Priority to AT0119103A priority patent/AT500521B1/de
Priority to BRPI0302496A priority patent/BRPI0302496C1/pt
Priority to ES200301811A priority patent/ES2224869B1/es
Priority to DE10334820.4A priority patent/DE10334820B4/de
Priority to HR20030618A priority patent/HRP20030618B1/xx
Priority to SK976-2003A priority patent/SK287201B6/sk
Priority to KR1020030053032A priority patent/KR100966977B1/ko
Priority to RU2003124299/15A priority patent/RU2333000C2/ru
Priority to PL361518A priority patent/PL209644B1/pl
Priority to HU0302441A priority patent/HU230575B1/hu
Priority to FR0309459A priority patent/FR2852845B1/fr
Priority to CZ2003-2096A priority patent/CZ305023B6/cs
Priority to TR2003/01248A priority patent/TR200301248A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT001725A 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica. ITMI20021725A1 (it)

Priority Applications (29)

Application Number Priority Date Filing Date Title
IT001725A ITMI20021725A1 (it) 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica.
IL156615A IL156615A (en) 2002-08-01 2003-06-24 Antibiotic preparations containing phosphomycin tromethamol and stabilizer
ZA200305040A ZA200305040B (en) 2002-08-01 2003-06-27 Pharmaceutical compositions with antibiotic activity.
NL1023790A NL1023790C2 (nl) 2002-08-01 2003-07-01 Farmaceutische samenstellingen met antibiotische activiteit.
PT102995A PT102995B (pt) 2002-08-01 2003-07-07 Composicoes farmaceuticas com actividade antibiotica
CA2434927A CA2434927C (en) 2002-08-01 2003-07-10 Pharmaceutical compositions with antibiotic activity
US10/615,781 US7303755B2 (en) 2002-08-01 2003-07-10 Pharmaceutical compositions with antibiotic activity
CO03058787A CO5480297A1 (es) 2002-08-01 2003-07-11 Composiciones farmaceuticas en forma de granulado soluble que contienen fosfomycin tromethamol y un estabilizante
CH01238/03A CH696718A5 (it) 2002-08-01 2003-07-15 Composizioni farmaceutiche ad attivita antibiotica.
GR20030100300A GR20030100300A (el) 2002-08-01 2003-07-15 Φαρμακευτικες συνθεσεις με αντιβιοτικη δραση
FI20031078A FI120080B (fi) 2002-08-01 2003-07-16 Farmaseuttisia koostumuksia, joilla on antibioottinen vaikutus
DK200301097A DK178348B1 (da) 2002-08-01 2003-07-22 Farmaceutiske sammensætninger med antibiotikumaktivitet
JP2003200437A JP4395338B2 (ja) 2002-08-01 2003-07-23 抗生物質活性を有する薬学的組成物
SI200300194A SI21259B (sl) 2002-08-01 2003-07-24 Farmacevtski pripravki z antibiotičnim delovanjem
SE0302129A SE527466C2 (sv) 2002-08-01 2003-07-25 Stabilisering av fosfomycin trometamol
BE2003/0427A BE1017903A3 (fr) 2002-08-01 2003-07-28 Compositions pharmaceutiques a activite antibiotique.
AT0119103A AT500521B1 (de) 2002-08-01 2003-07-28 Stabilisierte pharmazeutische zusammensetzung enthaltend antibiotisches fosfomycin-tromethamol
BRPI0302496A BRPI0302496C1 (pt) 2002-08-01 2003-07-29 composições farmacêuticas com atividade antibiótica
ES200301811A ES2224869B1 (es) 2002-08-01 2003-07-30 Composiciones farmaceuticas con actividad antibiotica.
DE10334820.4A DE10334820B4 (de) 2002-08-01 2003-07-30 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität
HR20030618A HRP20030618B1 (en) 2002-08-01 2003-07-30 Pharmaceutical compositions having antibiotic effect
FR0309459A FR2852845B1 (fr) 2002-08-01 2003-07-31 Compositions pharmaceutiques a activite antibiotique
HU0302441A HU230575B1 (hu) 2002-08-01 2003-07-31 Antibiotikus hatású gyógyszerészeti készítmények
KR1020030053032A KR100966977B1 (ko) 2002-08-01 2003-07-31 항생 활성을 갖는 약제 조성물
SK976-2003A SK287201B6 (sk) 2002-08-01 2003-07-31 Použitie zlúčeniny na stabilizáciu fosfomycín trometamolu a farmaceutické prostriedky s obsahom týchto zlúčenín a fosfomycín trometamolu
RU2003124299/15A RU2333000C2 (ru) 2002-08-01 2003-07-31 Фармацевтические составы, обладающие антибиотической активностью
PL361518A PL209644B1 (pl) 2002-08-01 2003-07-31 Zastosowanie substancji oraz kompozycja farmaceutyczna
CZ2003-2096A CZ305023B6 (cs) 2002-08-01 2003-08-01 Farmaceutický prostředek
TR2003/01248A TR200301248A2 (tr) 2002-08-01 2003-08-01 Antibiyotik Aktiviteye Sahip Olan Farmasotik Kompozisyonlar.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001725A ITMI20021725A1 (it) 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica.

Publications (1)

Publication Number Publication Date
ITMI20021725A1 true ITMI20021725A1 (it) 2002-10-31

Family

ID=27638551

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001725A ITMI20021725A1 (it) 2002-08-01 2002-08-01 Composizioni farmaceutiche ad attivita' antibiotica.

Country Status (29)

Country Link
US (1) US7303755B2 (it)
JP (1) JP4395338B2 (it)
KR (1) KR100966977B1 (it)
AT (1) AT500521B1 (it)
BE (1) BE1017903A3 (it)
BR (1) BRPI0302496C1 (it)
CA (1) CA2434927C (it)
CH (1) CH696718A5 (it)
CO (1) CO5480297A1 (it)
CZ (1) CZ305023B6 (it)
DE (1) DE10334820B4 (it)
DK (1) DK178348B1 (it)
ES (1) ES2224869B1 (it)
FI (1) FI120080B (it)
FR (1) FR2852845B1 (it)
GR (1) GR20030100300A (it)
HR (1) HRP20030618B1 (it)
HU (1) HU230575B1 (it)
IL (1) IL156615A (it)
IT (1) ITMI20021725A1 (it)
NL (1) NL1023790C2 (it)
PL (1) PL209644B1 (it)
PT (1) PT102995B (it)
RU (1) RU2333000C2 (it)
SE (1) SE527466C2 (it)
SI (1) SI21259B (it)
SK (1) SK287201B6 (it)
TR (1) TR200301248A2 (it)
ZA (1) ZA200305040B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE740685C (de) * 1941-04-11 1943-10-26 Voigt & Haeffner Ag Viertakt-Regelschalter fuer Parallel-, Einzel- und Reihenschaltung von Heizwiderstaenden
ES2244333B1 (es) * 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA030999B1 (ru) 2009-10-02 2018-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Применение фармацевтической композиции, включающей ингибитор дпп-4 и гидрохлорид метформина
EA021876B1 (ru) * 2010-09-20 2015-09-30 ЛИМОНОВ, Виктор Львович Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения
ES2385158B1 (es) * 2010-12-24 2013-05-28 Arafarma Group, S.A. Composición farmacéutica de fosfomicina
CN102579466A (zh) * 2011-01-10 2012-07-18 王乐 一种磷霉素或磷霉素精氨酸盐与精氨酸的组合物
US8604078B2 (en) * 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
ITTO20130839A1 (it) * 2013-10-16 2015-04-17 C & G Farmaceutici S R L Composizione a base di fosfomicina trometamolo
DE102014218913A1 (de) * 2014-09-19 2016-03-24 Heraeus Medical Gmbh Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver
CN104546689B (zh) * 2015-01-07 2019-01-25 同方药业集团有限公司 一种含有甲硝唑的药物组合物
US20180360855A1 (en) 2015-12-25 2018-12-20 Yusuf Toktamis ÖGÜN The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections
CA3147662A1 (en) 2021-02-10 2022-08-10 Labiana Health, S.L. New fosfomycin tablet formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852434A (en) * 1970-09-11 1974-12-03 Merck & Co Inc Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
IT1161974B (it) 1978-02-02 1987-03-18 Italchemi Spa Derivti dell acido cis.i 2 epossipropilfosfonico loro procedimento di preparazione e composizioni farmaceutiche che li contengono
IT1112282B (it) * 1978-07-19 1986-01-13 Zambon Spa Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
CH660305A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
US5182274A (en) * 1988-09-26 1993-01-26 Teijin Limited Stabilized aqueous preparation of active form of vitamin d3
US5191094A (en) * 1989-07-27 1993-03-02 Zambon Group S.P.A. Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability and processing
IT1231013B (it) 1989-07-27 1991-11-08 Zambon Spa Mono (2 ammonio 2 idrossimetil 1,3 propandiolo)(2r,cis) 1,2 epossipropil fosfonato avente migliorate caratteristiche di stabilita' e lavorabilita'.
IT1244543B (it) 1991-02-01 1994-07-15 La Fa Re Srl Uso topico della fosfomicina e dei suoi sali nella terapia delle infezioni vaginali e/o uretrali
FR2690340B1 (fr) 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
JPH09183730A (ja) * 1995-05-10 1997-07-15 Meiji Seika Kaisha Ltd ホスホマイシン鏡像異性体を含んでなる医薬
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
BR0112393A (pt) * 2000-06-21 2003-07-08 Internat Health Man Associates Composições e processos para aperfeiçoamento de absorção oral de agentes antimicrobiais
US6699505B2 (en) * 2000-10-17 2004-03-02 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by compexing with cyclodextrins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents

Also Published As

Publication number Publication date
CO5480297A1 (es) 2005-01-28
CA2434927A1 (en) 2004-02-01
CZ305023B6 (cs) 2015-04-01
BRPI0302496B8 (pt) 2016-09-13
HRP20030618B1 (en) 2011-10-31
BRPI0302496C1 (pt) 2021-05-25
IL156615A0 (en) 2004-01-04
AT500521A1 (de) 2006-01-15
BRPI0302496B1 (pt) 2015-07-28
PT102995A (pt) 2004-02-27
SE0302129L (sv) 2004-02-02
PT102995B (pt) 2004-07-30
HRP20030618A2 (en) 2004-04-30
DK200301097A (da) 2004-02-02
FI20031078A0 (fi) 2003-07-16
ZA200305040B (en) 2004-05-11
HUP0302441A2 (hu) 2005-07-28
PL209644B1 (pl) 2011-09-30
HU230575B1 (hu) 2017-02-28
HU0302441D0 (en) 2003-09-29
JP4395338B2 (ja) 2010-01-06
RU2003124299A (ru) 2005-01-20
KR100966977B1 (ko) 2010-06-30
SK287201B6 (sk) 2010-03-08
ES2224869A1 (es) 2005-03-01
PL361518A1 (en) 2004-02-09
US20040022866A1 (en) 2004-02-05
BE1017903A3 (fr) 2009-11-03
IL156615A (en) 2008-11-26
RU2333000C2 (ru) 2008-09-10
CZ20032096A3 (cs) 2004-03-17
FI120080B (fi) 2009-06-30
SE527466C2 (sv) 2006-03-14
CA2434927C (en) 2011-10-18
DE10334820B4 (de) 2020-02-06
SI21259B (sl) 2012-12-31
TR200301248A2 (tr) 2004-02-23
GR20030100300A (el) 2004-04-22
JP2004067682A (ja) 2004-03-04
CH696718A5 (it) 2007-10-31
AT500521B1 (de) 2007-11-15
NL1023790A1 (nl) 2004-02-03
SI21259A (sl) 2004-02-29
DE10334820A1 (de) 2004-03-11
FR2852845B1 (fr) 2006-01-06
NL1023790C2 (nl) 2004-03-10
DK178348B1 (da) 2016-01-04
SK9762003A3 (en) 2004-02-03
BR0302496A (pt) 2004-08-24
US7303755B2 (en) 2007-12-04
KR20040012569A (ko) 2004-02-11
FR2852845A1 (fr) 2004-10-01
SE0302129D0 (sv) 2003-07-25
ES2224869B1 (es) 2007-07-01
FI20031078A (fi) 2004-02-02

Similar Documents

Publication Publication Date Title
NO20015175L (no) Farmasöytisk sammensetning
PT1501534E (pt) Formulacoes farmaceuticas
ATE380544T1 (de) Umhüllte feste darreichungsform
FI991485A0 (fi) Uusi farmaseuttinen koostumus
PT1242087E (pt) Composicoes farmaceuticas
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
FI20011478A (fi) Farmaseuttinen koostumus
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita' analgesica
ITMI20021725A1 (it) Composizioni farmaceutiche ad attivita' antibiotica.
PT1239832E (pt) Composicoes farmaceuticas
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20014926L (no) Farmasöytiske forbindelser
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
FI4488U1 (fi) Farmaseuttinen koostumus
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ITMI20020624A0 (it) Composizioni ad attivita' biostimolante
IS7581A (is) Lyfjasamsetning
ITRM20020402A0 (it) Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine.
ITMI20011995A0 (it) Sostanze ad attivita' antinfiammatoria
NO20044164L (no) Farmasoytiske sammensetninger
DE10107261B4 (de) Pharmazeutische Zusammensetzung
ITRM20030053A0 (it) Associazione di farmaci antidiabetici.
ITTO20021048A1 (it) 3-acil derivati di 4-idrossicumarina e suoi isosteri ad attivita' antibiotica.
ITMI20020639A0 (it) Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil -urea